Variability in response to albuminuria‐lowering drugs: true or random?
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13217
Abstract: AIMS Albuminuria-lowering drugs have shown different effect size in different individuals. Since urine albumin levels are known to vary considerably from day-to-day, we questioned whether the between-individual variability in albuminuria response after therapy initiation reflects… read more here.
Keywords: response; treatment; variability; drug ... See more keywords
The albuminuria‐lowering response to dapagliflozin is variable and reproducible among individual patients
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes"
DOI: 10.1111/dom.12936
Abstract: Albuminuria reduction is essential for renal and cardiovascular protection. We characterized the efficacy of dapagliflozin, a sodium‐glucose co‐transporter 2 inhibitor, on albuminuria. Secondly, we assessed whether the albuminuria‐lowering effect varies among patients, and whether this… read more here.
Keywords: response dapagliflozin; lowering response; albuminuria lowering; dapagliflozin variable ... See more keywords
Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study
Sign Up to like & getrecommendations! Published in 2023 at "Diabetes"
DOI: 10.1111/dom.15033
Abstract: To evaluate the albuminuria‐lowering effect of dapagliflozin, exenatide, and the combination of dapagliflozin and exenatide in patients with type 2 diabetes and microalbuminuria or macroalbuminuria. read more here.
Keywords: exenatide combination; patients type; effect dapagliflozin; lowering effect ... See more keywords